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Enterovirus 71 (EV71) is the major etiological agent of
hand, foot, and mouth disease (HFMD). Early studies
showed that EV71-infected patients with severe
complications exhibited elevated plasma levels of
IL-1b, indicating that EV71 may activate inflamma-
somes. Our current study demonstrates that the
NLRP3 inflammasome plays a protective role against
EV71 infection of mice in vivo. EV71 replication in
myeloid cells results in the activation of the NLRP3
inflammasome and secretion of IL-1b. Conversely,
EV71 counteracts inflammasome activation through
cleavage of NLRP3 by viral proteases 2A and 3C,
which cleave NLRP3 protein at the G493-L494 or
Q225-G226 junction, respectively. Moreover, EV71
3C interacts with NLRP3 and inhibits IL-1b secretion
when expressed in mammalian cells. These results
thus reveal a set of reciprocal regulations between
enterovirus 71 and the NLRP3 inflammasome.INTRODUCTION
Since its first identification in 1969, enterovirus 71 (EV71) has
caused many epidemics in the world, especially in the Asia-Pa-
cific region, manifested by hand, foot, and mouth disease
(HFMD) (Huang et al., 2012). Infection with EV71 can lead to
severe neurological complications such as encephalitis, acute
flaccid paralysis, and pulmonary edema in children (Ooi et al.,
2010). EV71 belongs to the genus Enteroviruswithin the Picorna-
viridae family, which is a non-enveloped virus with a single
positive-stranded RNA genome. The genome encodes a single
polyprotein precursor that gets processed into mature proteins
by viral-encoded proteases 2A and 3C (Solomon et al., 2010).
These proteases also cleave host factors to dampen immune re-
sponses. For example, 3C cleaves TRIF, IRF7, and IRF9 to inhibit
innate immune responses (Hung et al., 2011; Lei et al., 2011,42 Cell Reports 12, 42–48, July 7, 2015 ª2015 The Authors2013b); 2A inhibits interferon responses by cleaving interferon
receptor (IFNAR) and MAVS (Lu et al., 2012; Wang et al., 2013a).
Although EV71 utilizes various approaches to control immune
responses, the mammalian host can still mount an effective
defense against infection of this virus. Several studies showed
that EV71-infected patients, particularly those with neurologic
complications, carried elevated levels of cytokines and chemo-
kines, including interleukin-1b (IL-1b), IL-6, and IL-8 (Bek and
McMinn, 2010; Griffiths et al., 2012; Lin et al., 2003). Upon EV71
infection, human-monocyte-derived macrophages produce pro-
inflammatory cytokines IL-1b, IL-6, and tumor necrosis factor a
(TNF-a), although peripheral blood mononuclear cells (PBMCs)
frompatientswith pulmonary edemaexhibit lower IL-1b and inter-
feron-g (IFN-g) levels than PBMCs from individuals with mild
symptoms (Chang et al., 2006; Gong et al., 2012). These observa-
tions indicate that the inflammatory response induced by EV71
may involve the activation of inflammasomes.
The inflammasome is a multi-protein complex that senses
infection or danger signals in the cell to control the maturation
and secretion of the pleiotropic pro-inflammatory cytokines
IL-1b and IL-18. To date, several inflammasomes have been
identified, of which the NLRP3 inflammasome is the most exten-
sively studied (Lamkanfi and Dixit, 2014). Upon activation,
NLRP3 oligomerizes via homotypic interactions between
NACHT domains and thereby presents clustered Pyrin domains
for interaction with the Pyrin domain of ASC. Clustered ASC in
turn recruits pro-caspase-1 via the CARD-CARD interaction
and induces proximity-induced auto-cleavage of caspase-1
(Lu et al., 2014). Activated caspase-1 tetramer cleaves a wide
range of proteins involved in various functions such as cell
death and non-canonical protein secretion (Keller et al., 2008).
NLRP3 inflammasome senses a plethora of pathogens and
danger-associated molecular patterns (DAMPs), including envi-
ronmental irritants, endogenous danger signals, and alum adju-
vants (Schroder et al., 2010). Sendai virus and influenza A
virus are the first reported viruses that activate the NLRP3
inflammasome (Kanneganti et al., 2006). Subsequent studies
have shown that modified vaccinia virus ankara (MVA), enceph-
alomyocarditis virus (EMCV), and adenovirus can also induce
Figure 1. The NLRP3 Inflammasome Is Pro-
tective against EV71 Infection In Vivo
(A) EV71 (5 3 105 PFU) was intracerebrally (i.c.)
injected into 3-day-old WT (n = 52), Nlrp3/ (n =
26), Asc/ (n = 34), and Caspase-1/ (n = 52)
mice. Mean scores were recorded for 15 days.
Scoring method: +10, front or rear limb lame-
ness; +20, both front and rear limb lameness; +30,
death. Two-way ANOVA analysis showed that the
p value was < 0.0001 when comparing the gene-
deficient mice with WT control mice.
(B) Disease incidence for mice in (A).
(C) Indicated mice were i.c. infected with EV71 as
in (A). 48 hr later, brain homogenates were
analyzed for production of IL-6 and TNF-a via
ELISA and depicted as cytokine concentrations
normalized to tissue weight.
(D) Mice were infected as in (A). 9 days later,
hindleg femur skeletal muscle was sectioned for
H&E staining. The upper panel shows the low-
scale images (scale bar, 200 mM), and the lower
panel shows the high-scale image for the indi-
cated areas from the upper panel.
(E) Real-time PCR detection of cytokine expres-
sion in the muscle from mice in (D).
(F) Real-time PCR detection of EV71 virus in the
brain of mice in (D).
Values in (E) and (F) represent the mean ± SEM.
Error bars represent SEM. **p < 0.01, *p < 0.05.IL-1b secretion in an NLRP3-dependent manner (Barlan et al.,
2011; Delaloye et al., 2009).
Our present study reveals that the NLRP3 inflammasome
plays a protective role against EV71 infection in vivo. Further-
more, we found that EV71 proteases 2A and 3C regulate inflam-
masome activity through cleavage of NLRP3. Our results thus
shed light on the physiopathologic relevance of the NLRP3 in-
flammasome during EV71 infection, which may provide thera-
peutic targets for anti-EV71 treatment.
RESULTS
The NLRP3 Inflammasome Protects Mice from EV71
Infection
To investigate the potential involvement of inflammasome
against EV71 infection, infant mice were infected with EV71 virus
through intracerebral injection to mimic neurological infection
(Figure 1). In this experiment, phenotypes of C57BL/6-back-
ground mice deficient for NLRP3, ASC, or caspase-1 were
compared with C57BL/6 wild-type (WT) mice. Since C57BL/6
mice are more resistant to EV71 infection than ICR mice, we
observed only a low level of death (data not shown). However,
it was obvious that NLRP3-, ASC-, and caspase-1-deficient
mice clearly exhibited more severe disease than WT mice ac-
cording to a scoring method (Figure 1A). The mice deficient for
NLRP3 inflammasome showed earlier occurrence of disease,
stronger paralysis, and delayed recovery compared with WT an-imals. Themorbidity rates of these gene-deficientmicewere also
higher than those of WT control mice (Figure 1B).
It is known that inflammasome activation is required for secre-
tion of mature IL-1b, which is not only a pyrogen by itself but also
a potent inducer of many pro-inflammatory cytokines and che-
mokines (Dinarello, 2011). Consistent with this, brain tissue
from NLRP3-inflammasome-deficient mice contained not only
a lower level of IL-1b but also decreased amounts of IL-6,
TNF-a, and IFN-g as compared with WT control at early time
point (2 days) postinfection (Figures 1C and S1A). With disease
progression, the mice developed lameness in their hindlegs.
H&E staining of hindleg femur muscle from mice 9 days after
infection revealed that NLRP3-inflammasome-deficient animals
carried more severe necrotizing myositis and stronger inflamma-
tory cell infiltration (Figures 1D and S1B). At this stage, the
expression of inflammatory cytokines and chemokines was
also higher in the muscle of mice deficient for NLRP3, ASC, or
caspase-1 than in WT mice (Figures 1E and S1C). Accordingly,
there was higher EV71 viral load in these deficient mice in the
brain 9 days after infection (Figure 1F). These data thus indicate
that the NLRP3 inflammasome plays a protective role against
EV71 infection in mice.
EV71 Infection Induces IL-1b Secretion in Myeloid Cells
To explore whether EV71 activates the NLRP3 inflammasome
in vitro, we infected human monocytic cell line THP-1 cells with
EV71 virus. A dose-dependent IL-1b secretion was detected inCell Reports 12, 42–48, July 7, 2015 ª2015 The Authors 43
Figure 2. EV71 Infection Induces IL-1b Secretion in Myeloid Cells
(A) IL-1b secretion in THP-1 cells infected with EV71 at different multiplicities of
infection (MOIs).
(B) VP0 and VP2 of EV71 expression in THP-1 cells.
(C and D) Expression of mature IL-1b and IL-18 in the supernatants of THP-1
cells treated with EV71 for different time periods.
(E–G) IL-1b secretion in Mono Mac 6 cells (E), human PBMCs (F), and mouse
BMDCs (G) after treatment with EV71 or LPS.
(H) IL-1b secretion in UV-inactivated EV71-treated THP-1 cells.
(I) EV71-specific antibody staining in THP-1 cells infected with normal EV71 or
UV-inactivated EV71.
Values represent the mean of triplicate samples ± SEM. Data are repre-
sentative of three independent experiments. Error bars represent SEM.
***p < 0.001, **p < 0.01, *p <0.05.the supernatant (Figure 2A). Accordingly, increased expression
of EV71 VP0 and VP2 proteins was detected in the cell lysates,
indicating an active viral replication (Figure 2B). Time-course as-
says also showed increased secretion of IL-1b and IL-18 (Figures
2C and 2D). Viral titer in the supernatant increased accordingly
(Figure S2A). Moreover, EV71 infection of THP-1-derivedmacro-
phages, human monocytic cell line Mono Mac 6 cells, primary
humanPBMCs, andmouse bone-marrow-derived dendritic cells
(BMDCs) also resulted in IL-1b secretion, indicating that EV7144 Cell Reports 12, 42–48, July 7, 2015 ª2015 The Authorsactivates the inflammasome to stimulate mature IL-1b secretion
(Figures 2E–2G and S2B). These results indicate that infection
with EV71 causes IL-1b secretion inmyeloid cells in both humans
and mice.
To establish infection, EV71 enters host cells through clathrin-
dependent endocytosis (Hussain et al., 2011). We found that two
clathrin-dependent endocytosis inhibitors, dynamin inhibitory
peptide (DIP) and chlorpromazine (CPZ), inhibited EV71-medi-
ated IL-1b production (Figure S2C), indicating that EV71 entry
was required for IL-1b induction. Rupintrivir, an EV71 replication
inhibitor, also inhibited EV71-induced IL-1b secretion (Fig-
ure S2D). Finally, UV rays or heat-inactivated EV71 virus failed
to replicate or induce IL-1b secretion in THP-1 cells (Figures
2H, 2I, and S2E). Together, these results indicate that EV71 entry
and replication are required for IL-1b secretion.
EV71 Infection Activates the NLRP3 Inflammasome
Since caspase-1 activation and ASC oligomerization are the
direct indicators for inflammasome activation (Wang et al.,
2013b), we examined the caspase-1 cleavage and ASC pyropto-
some formation in EV71-infected THP-1 cells. As shown in Fig-
ures 3A and 3B, mature caspase-1 and IL-1b were detected in
the supernatant and ASC oligomer was formed after EV71 infec-
tion. Lipopolysaccharide (LPS) served as a positive control in this
experiment.
Moreover, we found that the inhibitor of caspase-1 AC-YVAD-
CHO strongly decreased EV71-induced IL-1b secretion, indi-
cating that EV71-induced IL-1b secretion was caspase-1 depen-
dent (Figure 3C). In addition, high-concentration K+ treatment
blocked EV71-induced IL-1b secretion (Figure 3D). Furthermore,
the NLRP3 inhibitor glibenclamide (glyburide) also inhibited
EV71-induced IL-1b production (Figure 3E). To directly assess
the involvement of the NLRP3 inflammasome in EV71-induced
IL-1b secretion, we transfected small interfering RNAs (siRNAs)
to silence the expression of ASC, NLRP3, and caspase-1 in
THP-1 cells before EV71 infection (Figure S3A). EV71-induced
IL-1b secretion, but not inflammasome-independent IL-8 pro-
duction from knockdown cells, was clearly decreased (Figures
3F and S3B). Similar results were obtained in ASC- or NLRP3-
deficient THP-1 cells (Figures 3G and S3C). Furthermore, these
findings were confirmed with BMDCs from WT, Nlrp3/,
Asc/, or Caspase-1/ mice. Upon EV71 infection, BMDCs
deficient for NLRP3 inflammasome exhibited decreased secre-
tion of IL-1b compared with WT cells (Figure 3H), while TNF-a
production was not changed (Figure S3D). Taken together, these
data indicate that EV71 infection activates the NLRP3 inflamma-
some and that the activity of NLRP3 is required for EV71-induced
IL-1b secretion.
EV71 Proteases 2A and 3C Cleave NLRP3 and Inhibit
NLRP3 Inflammasome Activation
We noticed that in NLRP3-, ASC-, and caspase-1-knockdown
THP-1 cells, EV71 replication was more active, as indicated by
higher viral titers in the supernatants (Figure S4A). A similar result
was observed in NLRP3- or ASC-deficient THP-1 cells (Fig-
ure S4B). These data indicated that the NLRP3 inflammasome
was required for the control of EV71 replication, which was
consistent with our in vivo study (Figure 1). On the contrary,
Figure 3. EV71 Activates the NLRP3 Inflammasome
(A) Detection of mature IL-1b and caspase-1 in the supernatants of THP-1 cells treated with EV71 or LPS.
(B) ASC oligomerization in THP-1-derived macrophages.
(C–E) THP-1 cells were incubated with YVAD (50 mM) (C), KCl (40 mM) (D), or glibenclamide (25 mg/ml) (E) for 1 hr and then infected with EV71 (MOI = 10) for 24 hr.
Supernatants were harvested for detection of IL-1b with ELISA.
(F) IL-1b secretion in THP-1 cells expressing siRNAs targeting NLRP3, ASC, and caspase-1 after EV71 infection.
(G) THP-1, defNLRP3-THP-1, or defASC-THP-1 cells were infected with EV71 at indicated MOIs. The release of IL-1b was quantified via ELISA.
(H) BMDCs fromWT,Nlrp3/,Asc/, andCaspase-1/micewere infectedwith EV71 and the supernatants were harvested for determination of IL-1b secretion
via ELISA.
Values represent the mean of triplicate samples ± SEM. Data are representative of three independent experiments. Error bars represent SEM. ***p < 0.001,
**p < 0.01, *p <0.05. NS, not significant.EV71 has evolved approaches to dodge or counteract the host
immune response to establish infection (Hung et al., 2011; Lei
et al., 2011, 2013b; Lu et al., 2012; Wang et al., 2013a). To inves-
tigate whether EV71 3C or 2A can target NLRP3 via cleavage,
recombinant 3C and 2A proteases were purified and incubated
with 293T cell extracts expressing NLRP3. The 3C and 2A
proteases cleaved NLRP3 protein, producing a 90-kDa or 65-
kDa fragment, respectively (Figure 4A). An immunoprecipitation
assay confirmed the interaction between NLRP3 and 3C when
co-transfected in 293T cells (Figure S4C).
To define the cleavage site, we generated a series of human
NLRP3 mutants. The mutants Q250A, Q269A, Q303A, and
Q323A were still cleaved by the 3C protease (Figure 4B). How-
ever, the Q225A mutant was resistant to cleavage by 3C (lane
4, Figure 4B), suggesting the Q225-G226 pair is a cleavage site
for 3C. Mouse NLRP3 also carries this cleavage site (Figure S4D)
and can be cleaved by 3C (Figure S4E). Moreover, the cleavage
was NLRP3 specific, since AIM2, ASC, caspase-1, and IL-1b
were not cleaved by 3C (Figure S4F). Similarly, we identified the
G493-L494 pair as the cleavage site for 2A (Figure 4D).
Since 3CcleavesNLRP3, itmay also inhibit the activation of the
NLRP3 inflammasome. To address this issue, 293T cells weretransiently transfected with plasmids expressing NLRP3, ASC,
pro-capase-1, and pro-IL-1b (Komune et al., 2011). It was shown
that 3C expression dose-dependently reduced IL-1b secretion
from293Tcells reconstitutedwith theNLRP3 inflammasome (Fig-
ure 4C). The cleavage of NLRP3 was correlated with 3C expres-
sion (Figure S4G). Furthermore, EV71 viral infection cleaved
ectopic-expressed human and mouse NLRP3 in 293T cells (Fig-
ure 4E). Importantly, the cleavage fragments 225-N and 225-C
decreased IL-1b secretion induced by LPS in THP-1 cells
compared to WT-NLRP3 (Figure S4H). Moreover, expression of
the cleavage-resistant Q225A mutant of NLRP3 led to clearly
elevated induction of IL-1b upon EV71 infection (Figure 4F).
In addition, expression of 3C in THP-1 macrophages inhibited
IL-1b secretion induced by nigericin, but not poly(dA:dT) (Fig-
ure 4G), indicating that AIM2 was not targeted by 3C. Moreover,
the protease activity of EV71-3C is necessary for the cleavage
of NLRP3, as the 3C protease inhibitor rupintrivir, but not the cas-
pase inhibitor Z-VADor the proteasome inhibitorMG132, blocked
3C-mediated NLRP3 cleavage (Figure S4I). It is known that H40D
or C147S substitution of 3C protein abrogates protease activity
and thatR84QorV154Ssubstitutionaffects itsRNAbindingactiv-
ity. From our mutational analysis, it was found that WT 3C led toCell Reports 12, 42–48, July 7, 2015 ª2015 The Authors 45
Figure 4. The Cleavage of NLRP3 by EV71 2A and 3C Proteases Inhibits NLRP3 Inflammasome Activity
(A) Cell extracts expressing NLRP3were incubated with the recombinant 2A, 2Amutant (C110A), 3C, or 3Cmutant (C147S) proteins. Samples were processed for
immunoblotting using the LI-COROdyssey dual-color system. Two antibodies that recognize NLRP3 (Flag, C-terminal of NLRP3, 800 nm, green; NLRP3, 1–93 aa,
700 nm, red) were used. An overlay of two channels is shown in the ‘‘merge’’ panel. Bottom panel shows the expression of 2A and 3C variants.
(B) 293T cells were transfected with wild-type NLRP3 or NLRP3 mutants as indicated along with GFP or GFP-3C. After 24 hr, cell lysates were subjected to
immunoblotting.
(C) 293T cells were transfected with plasmids encoding NLRP3, pro-caspase-1, pro-IL-1b, and ASC, alone with increasing amounts of GFP-3C. 24 hr after
transfection, supernatants were harvested to analyze IL-1b production via ELISA and immunoblotting.
(D) 293T cell extracts overexpressing NLRP3 variants were incubated with the recombinant 2A protease. Samples were processed for immunoblotting as in (A).
(E) 293T cells were transfected with human or mouse NLRP3. Then, cells were treated with EV71. 24 hr after infection, cell lysates were analyzed via immu-
noblotting.
(F) shNLRP3 THP-1 cells were transfected with GFP, NLRP3, or NLRP3-Q225A plasmids through electroporation. 48 hr later, cells were mock treated or infected
with EV71 for 24 hr. IL-1b in supernatants was analyzed via ELISA. NLRP3, EV71 3C protease, and actin were detected through immunoblotting.
(G) IL-1b secretion from nigericin- or poly(dA:dT)-treated THP-1 macrophages expressing EV71-3C. Error bars represent SEM. **p < 0.01.
(H) NLRP3 cleavage by 3C variants in 293 T cells.
(I) As in (C), except that 293T cells were transfected with GFP-3C variants alone with inflammasome plasmids. Error bars represent SEM. ***p < 0.001. NS, not
significant.NLRP3 cleavage and resulted in the inhibition of IL-1b secretion
(Figures 4H and 4I). However, H40D and C147S were unable to
induce NLRP3 cleavage or to inhibit IL-1b secretion. In contrast,
R84QandV154Smutationwasstill functioning asWT-3C (Figures
4Hand4I). Taken together, thesedata show that EV71 3Ccleaves
NLRP3 to inhibit NLRP3-mediated IL-1b secretion and that 3C
protease activity plays a critical role in this process.46 Cell Reports 12, 42–48, July 7, 2015 ª2015 The AuthorsDISCUSSION
Although progress has been made in EV71 research since its
identification, a knowledge gapexistswith respect to the host im-
mune responses against EV71 infection. Here, we demonstrate
that the NLRP3 inflammasome plays a protective role against
EV71 infection. At an early time point after EV71 challenge,
NLRP3-inflammasome-deficient mice showed decreased IL-1b
secretion, which should be due to the lack of inflammasome ac-
tivity. Moreover, the levels of other pro-inflammatory cytokines
such as IFN-g, TNF-a, and IL-6 were also lower in mice deficient
for NLRP3 inflammasome compared with that in WT mice. This
was probably caused indirectly by the decrease of IL-18 and
IL-1b in these animals. At a later time point after EV71 infection,
mice deficient for the NLRP3 inflammasome exhibited uncon-
trolled viral replication and elevated levels of pro-inflammatory
cytokines and chemokines. This indicates that inflammasome
activity is critical for thecontrol ofEV71 via initiation of aneffective
inflammatory response at an early timepoint after infection. Once
EV71 establishes infection and amplifies in the host, it causes
inflammation in tissues such as brain and muscle, leads to dam-
age of these tissues in an inflammasome-independent manner,
and results in pathogenesis and death. Thus, the inflamma-
some-dependent response early after EV71 infection seems to
be beneficial to the host, while the inflammasome-independent
overwhelming inflammation at a later time point is deleterious in
our mouse model. Therefore, fine-tuning inflammasome activity
may be helpful to control EV71 infection.
Enterovirus 71 belongs to Picornaviruses family, which is a
large family of fast-evolving small RNA viruses including many
important human and animal pathogens (Tapparel et al., 2013).
As an important arm of innate immune defense, the NLRP3 in-
flammasome is not only critical for the control of EV71 infection,
as revealed in the present study, but also involved in responses
to other picornaviruses, as implied from early studies. EMCV vi-
roporin 2B and rhinovirus ion channel protein 2B were both able
to activate the NLRP3 inflammasome in cultured cells (Ito et al.,
2012; Triantafilou et al., 2013). Thus, based on our current finding
that the NLRP3 inflammasome is protective against EV71 infec-
tion, it is reasonable to speculate that it may also play a protec-
tive role against other picornaviruses.
Intriguingly, we find that EV71 not only activates the NLRP3 in-
flammasome but also inhibits inflammasome activation through
cleavage of NLRP3. On the one hand, this is not surprising,
because many pathogens are sensed by host innate immune
system, and they also have regulatory machinery to avoid or
inhibit immune responses (Taxman et al., 2010); on the other
hand, this makes it hard to understand the kinetics of inflamma-
some activation versus inhibition upon EV71 infection. Probably,
at the early phase of infection, RNA and proteins from EV71
induce NLRP3 protein expression and inflammasome assembly.
When the virus replicates and generates enough 3C and 2A pro-
teases at the later phase of infection, NLRP3 gets cleaved and
inflammasome activity is harnessed. There should be overlap-
ping time between these two phases. In fact, NLRP3 inflamma-
some activation by EV71 infection is much slower and weaker
than that from bacterial or fungal infections (Lei et al., 2013a; Ma-
riathasan et al., 2006). It is known that pathogens can use either
competitive protein homologs or their toxic proteins to bind and
inactivate inflammasome proteins (Gregory et al., 2011; LaRock
and Cookson, 2012; Taxman et al., 2010). Here, we discovered a
mechanism for the viral regulation of inflammasome, which is
that the viral proteases cleave NLRP3 as an anti-inflammasome
tactic. This may be a prevalent mechanism of various enterovi-
ruses to combat NLRP3 inflammasome activity.EXPERIMENTAL PROCEDURES
Mice
Asc- and Nlrp3-deficient mice have been described before (Mao et al., 2013;
Mariathasan et al., 2004). Caspase-1-deficient mice were from The Jackson
Laboratory and crossed onto the C57BL/6 genetic background for ten gener-
ations. Animal care and use and experimental procedures complied with na-
tional guidelines and were approved by the animal care and use committee
at Institut Pasteur of Shanghai.
Statistics
Statistical evaluation between control and experimental samples was per-
formed using the Student’s t test. p values < 0.05 were considered significant
(***p < 0.001, **p < 0.01, and *p < 0.05).
Detailed experimental procedures are included in Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.05.047.
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